Accredited official statistics

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, data up to July to September 2024

Updated 23 January 2025

Applies to England

Gram-negative bacteraemias (E. coli, Klebsiella spp. and P. aeruginosa)

Pseudomonas aeruginosa (P. aeruginosa) bacteraemia

July to September 2023: 8 out of every 100,000 persons developed a P. aeruginosa bacteraemia.

July to September 2024: 9 out of every 100,000 persons developed a P. aeruginosa bacteraemia.

Klebsiella species (Klebsiella spp.) bacteraemia

July to September 2023: 24 out of every 100,000 persons developed a Klebsiella spp. bacteraemia.

July to September 2024: 25 out of every 100,000 persons developed a Klebsiella spp. bacteraemia.

Escherichia coli (E. coli) bacteraemia

July to September 2023: 77 out of every 100,000 persons developed an E. coli bacteraemia.

July to September 2024: 79 out of every 100,000 persons developed an E. coli bacteraemia.

Staphylococcus aureus (S. aureus) MRSA and MSSA bacteraemia and Clostridioides difficile (C. difficile) infections

Methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia

July to September 2023: 1.4 out of every 100,000 persons developed an MRSA bacteraemia.

July to September 2024: 1.8 out of every 100,000 persons developed an MRSA bacteraemia.

Methicillin-susceptible Staphylococcus aureus (MSSA) bacteraemia

July to September 2023: 23 out of every 100,000 persons developed an MSSA bacteraemia.

July to September 2024: 24 out of every 100,000 persons developed an MSSA bacteraemia.

Clostridioides difficile (C. difficile) infection

July to September 2023: 30 out of every 100,000 persons developed a C. difficile infection.

July to September 2024: 37 out of every 100,000 persons developed a C. difficile infection.